Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1956 3
1957 2
1958 2
1959 3
1961 4
1962 7
1963 11
1964 26
1965 17
1966 13
1967 15
1968 20
1969 30
1970 30
1971 16
1972 20
1973 22
1974 29
1975 25
1976 21
1977 29
1978 37
1979 39
1980 42
1981 35
1982 60
1983 55
1984 72
1985 91
1986 123
1987 117
1988 120
1989 150
1990 119
1991 118
1992 163
1993 143
1994 159
1995 169
1996 170
1997 179
1998 159
1999 191
2000 196
2001 179
2002 197
2003 191
2004 207
2005 217
2006 245
2007 220
2008 238
2009 327
2010 322
2011 354
2012 378
2013 374
2014 368
2015 414
2016 351
2017 375
2018 407
2019 417
2020 497
2021 517
2022 444
2023 355
2024 339
2025 328
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,276 results

Results by year

Filters applied: . Clear all
Page 1
NMOSD and MOGAD: an evolving disease spectrum.
Uzawa A, Oertel FC, Mori M, Paul F, Kuwabara S. Uzawa A, et al. Among authors: mori m. Nat Rev Neurol. 2024 Oct;20(10):602-619. doi: 10.1038/s41582-024-01014-1. Epub 2024 Sep 13. Nat Rev Neurol. 2024. PMID: 39271964 Review.
ctDNA-based molecular residual disease and survival in resectable colorectal cancer.
Nakamura Y, Watanabe J, Akazawa N, Hirata K, Kataoka K, Yokota M, Kato K, Kotaka M, Kagawa Y, Yeh KH, Mishima S, Yukami H, Ando K, Miyo M, Misumi T, Yamazaki K, Ebi H, Okita K, Hamabe A, Sokuoka H, Kobayashi S, Laliotis G, Aushev VN, Sharma S, Jurdi A, Liu MC, Aleshin A, Rabinowitz M, Bando H, Taniguchi H, Takemasa I, Kato T, Kotani D, Mori M, Yoshino T, Oki E. Nakamura Y, et al. Among authors: mori m. Nat Med. 2024 Nov;30(11):3272-3283. doi: 10.1038/s41591-024-03254-6. Epub 2024 Sep 16. Nat Med. 2024. PMID: 39284954 Free PMC article.
Immunotherapy for esophageal cancer: Where are we now and where can we go.
Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nabeshima K, Nishi T, Mori M. Shoji Y, et al. Among authors: mori m. World J Gastroenterol. 2024 May 21;30(19):2496-2501. doi: 10.3748/wjg.v30.i19.2496. World J Gastroenterol. 2024. PMID: 38817664 Free PMC article. Review.
SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis.
Ogawa A, Izumikawa K, Tate S, Isoyama S, Mori M, Fujiwara K, Watanabe S, Ohga T, Jo U, Taniyama D, Kitajima S, Tanaka S, Onji H, Kageyama SI, Yamamoto G, Saito H, Morita TY, Okada M, Natsumeda M, Nagahama M, Kobayashi J, Ohashi A, Sasanuma H, Higashiyama S, Dan S, Pommier Y, Murai J. Ogawa A, et al. Among authors: mori m. Mol Cell. 2025 Mar 6;85(5):894-912.e10. doi: 10.1016/j.molcel.2025.01.008. Epub 2025 Feb 4. Mol Cell. 2025. PMID: 39909041 Free article.
Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.
Hashimoto M, Kojima Y, Sakamoto T, Ozato Y, Nakano Y, Abe T, Hosoda K, Saito H, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Hata T, Nagayama S, Kagawa K, Goto Y, Utou M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Takahashi K, Niida A, Hirose H, Hayashi S, Koseki J, Fukuchi S, Murakami K, Yoshizumi T, Kadomatsu K, Tobo T, Oda Y, Uemura M, Eguchi H, Doki Y, Mori M, Oshima M, Shibata T, Suzuki Y, Shimamura T, Mimori K. Hashimoto M, et al. Among authors: mori m. EBioMedicine. 2024 May;103:105102. doi: 10.1016/j.ebiom.2024.105102. Epub 2024 Apr 12. EBioMedicine. 2024. PMID: 38614865 Free PMC article.
In Response.
Lele AV, Vail EA, O'Reilly-Shah VN, deGrauw X, Domino KB, Walters AM, Fong CT, Gomez C, Naik BI, Mori M, Schonberger R, Deshpande R, Freundlich RE, Mathis MR, Mhyre J, Souter MJ. Lele AV, et al. Among authors: mori m. Anesth Analg. 2025 Jun 1;140(6):e77-e78. doi: 10.1213/ANE.0000000000007503. Epub 2025 Mar 25. Anesth Analg. 2025. PMID: 40131819 No abstract available.
CD163+ Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma.
Mori M, Sakamoto A, Kawakami R, Guo L, Slenders L, Mosquera JV, Ghosh SKB, Wesseling M, Shiraki T, Bellissard A, Shah P, Weinkauf CC, Konishi T, Sato Y, Cornelissen A, Kawai K, Jinnouchi H, Xu W, Vozenilek AE, Williams D, Tanaka T, Sekimoto T, Kelly MC, Fernandez R, Grogan A, Coslet AJ, Fedotova A, Kurse A, Mokry M, Romero ME, Kolodgie FD, Pasterkamp G, Miller CL, Virmani R, Finn AV. Mori M, et al. Circ Res. 2024 Jul 5;135(2):e4-e23. doi: 10.1161/CIRCRESAHA.123.324082. Epub 2024 Jun 11. Circ Res. 2024. PMID: 38860377 Free article.
Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children.
Domachowske J, Hamrén UW, Banu I, Baronio R, Basavaraju B, Koen A, Leach A, Mankad VS, Pannaraj PS, Soler-Palacin P, Takas T, Mori M, Villafana T; MUSIC Study Group. Domachowske J, et al. Among authors: mori m. Pediatrics. 2024 Oct 1;154(4):e2024066508. doi: 10.1542/peds.2024-066508. Pediatrics. 2024. PMID: 39257380 Clinical Trial.
Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome.
Guimarães GR, Maklouf GR, Teixeira CE, de Oliveira Santos L, Tessarollo NG, de Toledo NE, Serain AF, de Lanna CA, Pretti MA, da Cruz JGV, Falchetti M, Dimas MM, Filgueiras IS, Cabral-Marques O, Ramos RN, de Macedo FC, Rodrigues FR, Bastos NC, da Silva JL, Lummertz da Rocha E, Chaves CBP, de Melo AC, Moraes-Vieira PMM, Mori MA, Boroni M. Guimarães GR, et al. Among authors: mori ma. Nat Commun. 2024 Jul 7;15(1):5694. doi: 10.1038/s41467-024-49916-4. Nat Commun. 2024. PMID: 38972873 Free PMC article.
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan.
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H, Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T, Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C, Watanabe M, Fujihara K. Niino M, et al. Among authors: mori m. Mult Scler Relat Disord. 2024 Oct;90:105829. doi: 10.1016/j.msard.2024.105829. Epub 2024 Aug 17. Mult Scler Relat Disord. 2024. PMID: 39182455 Review.
10,276 results
You have reached the last available page of results. Please see the User Guide for more information.